Gene targeting or the use of a potent antagonist for the murine CCR5 receptor results in a significant reduction of liver fibrosis [18]; however, the exact role of CCR5, and which CCR5-expressing cell type is involved in HCC, remains unclear. This evidence concerns the gene CCR5 and hepatocellular carcinoma.